HDAC9 and non-small cell lung carcinoma: This property of NC combined with the synergistic therapeutic actions where LSL and GT functions to inhibit HDAC and Hsp90 signaling pathways was evaluated as a treatment of NSCLC (Figure 1) 52,53.